{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:55:59Z","timestamp":1763348159703,"version":"3.37.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Program for Academic Cooperation","award":["[Grant Numbers 2951\/2014]"],"award-info":[{"award-number":["[Grant Numbers 2951\/2014]"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11033-019-04639-4","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T06:12:59Z","timestamp":1549347179000},"page":"1873-1884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia"],"prefix":"10.1007","volume":"46","author":[{"given":"Aline Portantiolo","family":"Lettnin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Felipe","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Carrett-Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"dos Santos Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Werhli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s Delgado","family":"Ca\u00f1edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilma Santos","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-8600","authenticated-orcid":false,"given":"Ana Paula","family":"de Souza Votto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"4639_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2016.10.003","volume":"51","author":"ES Villodre","year":"2016","unstructured":"Villodre ES, Kipper FC, Pereira MB, Lenz G (2016) Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treat Rev N 51:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2016.10.003","journal-title":"Cancer Treat Rev N"},{"issue":"6859","key":"4639_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105\u2013111","journal-title":"Nature"},{"key":"4639_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.radonc.2013.06.003","volume":"108","author":"C Peitzsch","year":"2013","unstructured":"Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M, Dubrovska A (2013) Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol 108:378\u2013387","journal-title":"Radiother Oncol"},{"issue":"3","key":"4639_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14(3):275\u2013291","journal-title":"Cell Stem Cell"},{"key":"4639_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","volume":"31","author":"M Cojoc","year":"2015","unstructured":"Cojoc M, M\u00e4bert K, Muders MH, Dubrovska A (2015) A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semi Cancer Biol 31:16\u201327","journal-title":"Semi Cancer Biol"},{"key":"4639_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.molcel.2016.06.039","volume":"63","author":"Z Simandi","year":"2016","unstructured":"Simandi Z, Horvath A, Wright LC, Cuaranta-Monroy I, De Luca I, Karolyi K, Sauer S, Deleuze J-F, Gudas LJ, Cowley SM, Nagy L (2016) OCT4 acts as an integrator of pluripotency and signal-induced differentiation. Mol Cell 63:647\u2013661. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2016.06.039","journal-title":"Mol Cell"},{"key":"4639_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/MCB.17.1.154","volume":"17","author":"A Brehm","year":"1997","unstructured":"Brehm A, Ohbo K, Scholer H (1997) The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol 17:154\u2013162","journal-title":"Mol Cell Biol"},{"issue":"5","key":"4639_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/stem.419","volume":"28","author":"X Wang","year":"2010","unstructured":"Wang X, Dai J (2010) Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem cells (Dayton Ohio) 28(5):85\u201393. \n                    https:\/\/doi.org\/10.1002\/stem.419","journal-title":"Stem cells (Dayton Ohio)"},{"key":"4639_CR9","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/j.1460-2075.1989.tb08393.x","volume":"8","author":"HR Scholer","year":"1989","unstructured":"Scholer HR, Balling R, Hatzopoulos AK, Suzuki N, Gruss P (1989) Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 8:2551\u20132557","journal-title":"EMBO J"},{"issue":"6277","key":"4639_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/345686a0","volume":"345","author":"MH Rosner","year":"1990","unstructured":"Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345(6277):686\u2013692","journal-title":"Nature"},{"key":"4639_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/74199","volume":"24","author":"H Niwa","year":"2000","unstructured":"Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3\/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372\u2013376","journal-title":"Nat Genet"},{"key":"4639_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0092-8674(03)00394-5","volume":"113","author":"F Cavaleri","year":"2003","unstructured":"Cavaleri F, Scholer HR (2003) Nanog: a new recruit to the embryonic stem cell ochestra. Cell 113:551\u2013552","journal-title":"Cell"},{"key":"4639_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1023\/B:MBIL.0000015138.80503.81","volume":"38","author":"IE Deyev","year":"2004","unstructured":"Deyev IE, Polanovsky OL (2004) The oct genes and oct proteins. Mol Biol 38:48\u201355","journal-title":"Mol Biol"},{"issue":"7","key":"4639_CR14","doi-asserted-by":"publisher","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"Y-C Chen","year":"2008","unstructured":"Chen Y-C, Hsu H-S, Chen Y-W, Tsai T-H, How C-K, Wang C-Y, Hung S-C, Chang Y-L, Tsai M-L, Lee Y-Y, Ku H-H, Chou S-H (2008) Oct-4 expression maintained cancer stem like properties in lung cancer-derived CD-133 positive cells. PLoS ONE 3 (7):e2637","journal-title":"PLoS ONE"},{"key":"4639_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.scr.2015.06.006","volume":"15","author":"KR Salci","year":"2015","unstructured":"Salci KR, Leea JB, Mitchell RR, Orlando L, Fiebig-Comyn A, Shapovalova Z, Bhatia M (2015) Acquisition of pluripotency through continued environmental influence on OCT4-induced plastic human fibroblasts. Stem Cell Res 15:221\u2013230","journal-title":"Stem Cell Res"},{"key":"4639_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.leukres.2009.11.004","volume":"34","author":"DS Marques","year":"2010","unstructured":"Marques DS, Sandrini JZ, Boyle RT, Marins LF, Trindade GF (2010) Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leuk Res 34:757\u2013762","journal-title":"Leuk Res"},{"key":"4639_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S (2005) Tumor stem cells and drug resistance. Nat Rev Cancer 5:275\u2013284. \n                    https:\/\/doi.org\/10.1038\/nrc1590","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"4639_CR18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.biotechadv.2014.08.007","volume":"32","author":"J Guo","year":"2014","unstructured":"Guo J, Cahill MR, McKenna SL, O\u2019Driscoll CM (2014) Biomimetic nanoparticles for siRNA delivery in the treatment of leukemia. Biotechnol Adv 32(8):1396\u20131409. \n                    https:\/\/doi.org\/10.1016\/j.biotechadv.2014.08.007","journal-title":"Biotechnol Adv"},{"key":"4639_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1600-0609.2011.01689.x","volume":"87","author":"S Vaidya","year":"2001","unstructured":"Vaidya S, Ghosh K, Vundinti BR (2001) Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review. Eur J Haematol 87:381\u2013393","journal-title":"Eur J Haematol"},{"key":"4639_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389200043489199","volume":"5","author":"A Haimeur","year":"2004","unstructured":"Haimeur A, Conseil G, Deeley RG, Cole SP (2004) The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21\u201353","journal-title":"Curr Drug Metab"},{"key":"4639_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48\u201358","journal-title":"Nat Rev Cancer"},{"key":"4639_CR22","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1021\/mp200261n","volume":"8","author":"CP Wu","year":"2011","unstructured":"Wu CP, Hsieh CH, Wu YS (2011) The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol Pharm 8:1996\u20132011. \n                    https:\/\/doi.org\/10.1021\/mp200261n","journal-title":"Mol Pharm"},{"key":"4639_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","volume":"8","author":"GD Leonard","year":"2003","unstructured":"Leonard GD, Fojo T, Bates SE (2003) The role of ABC transporters in clinical practice. Oncologist 8:411\u2013424","journal-title":"Oncologist"},{"key":"4639_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2004.09.001","volume":"219","author":"J Fernandes","year":"2005","unstructured":"Fernandes J, Weinlich R, Castilho RO, Kaplan MAC, Amarante-Mendes GP, Gattass CR (2005) Pomolic acid triggers mitochondria-dependent apoptotic cell death in leukemia cell line. Cancer Lett 219:49\u201355","journal-title":"Cancer Lett"},{"key":"4639_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","volume":"580","author":"MM Gottesman","year":"2006","unstructured":"Gottesman MM, Ling V (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580:998\u20131009","journal-title":"FEBS Lett"},{"key":"4639_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.canlet.2008.09.021","volume":"274","author":"PJ Ferguson","year":"2009","unstructured":"Ferguson PJ, Brisson AR, Koropatnick J, Vincent MD (2009) Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene. Cancer Lett 274:279\u2013289","journal-title":"Cancer Lett"},{"key":"4639_CR27","first-page":"71","volume":"19","author":"T Fatemian","year":"2014","unstructured":"Fatemian T, Othman I, Chowdhury EH (2014) Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer. Drug Discov 19:71\u201378","journal-title":"Drug Discov"},{"key":"4639_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbrc.2005.09.157","volume":"337","author":"G Suo","year":"2005","unstructured":"Suo G, Han J, Wang X, Zhang J, Zhao Y, Dai J (2005) Oct4 pseudogenes are transcribed in cancers. Biochem Bioph Res Commun 337:1047\u20131051","journal-title":"Biochem Bioph Res Commun"},{"key":"4639_CR29","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1074\/jbc.C400587200","volume":"280","author":"D Pain","year":"2005","unstructured":"Pain D, Chirn G-W, Strassel C, Kemp DM (2005) Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem 280:6265\u20136268","journal-title":"J Biol Chem"},{"key":"4639_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.ge.19.120185.001345","volume":"19","author":"E Vanin","year":"1985","unstructured":"Vanin E (1985) Processed pseudogenes: characteristics and evolution. Ann Rev Genet 19:253\u2013272","journal-title":"Ann Rev Genet"},{"key":"4639_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1261\/rna.2658311","volume":"17","author":"RC Pink","year":"2011","unstructured":"Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L, Carter DRF (2011) Pseudogenes: pseudo-functional or key regulators in health and disease. RNA 17:792\u2013798","journal-title":"RNA"},{"key":"4639_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/424526","author":"Y Tutar","year":"2012","unstructured":"Tutar Y (2012) Pseudogenes. Comp Funct Genom. \n                    https:\/\/doi.org\/10.1155\/2012\/424526","journal-title":"Comp Funct Genom"},{"key":"4639_CR33","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.biochi.2011.07.024","volume":"93","author":"EM Muro","year":"2011","unstructured":"Muro EM, Mah N, Andrade-Navarro MA (2011) Functional evidence of post-transcriptional regulation by pseudogenes. Biochimie 93:1916\u20131921. \n                    https:\/\/doi.org\/10.1016\/j.biochi.2011.07.024","journal-title":"Biochimie"},{"issue":"8","key":"4639_CR34","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/carcin\/bgt139","volume":"34","author":"L Wang","year":"2013","unstructured":"Wang L, Guo Z-Y, Zhang R, Xin B, Chen R, Zhao J, Wang T, Wen W-H, Jia L-T, Yao L-B, Yang A-G (2013) Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis 34(8):1773\u20131781. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgt139","journal-title":"Carcinogenesis"},{"key":"4639_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-013-1761-0","volume":"383","author":"N Daflon-Yunes","year":"2013","unstructured":"Daflon-Yunes N, Pinto-Silva FE, Vidal RS, Novis BF, Berguetti T, Lopes RRS, Polycarpo C, Rumjanek VM (2013) Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms. Mol Cell Biochem 383:123\u2013135","journal-title":"Mol Cell Biochem"},{"key":"4639_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10616-006-9028-1","volume":"51","author":"A Delgado-Ca\u00f1edo","year":"2006","unstructured":"Delgado-Ca\u00f1edo A, Dos Santos DG, Chies JAB, Kvitko K, Nardi NB (2006) Optimization of na electroporation protocol using the K562 cell line as a model: role of cell cycle phase and cytoplasmic DNAses. Cytotechnology 51:141\u2013148. \n                    https:\/\/doi.org\/10.1007\/s10616-006-9028-1","journal-title":"Cytotechnology"},{"key":"4639_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:1\u201311","journal-title":"Genome Biol"},{"issue":"18","key":"4639_CR38","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","volume":"28","author":"B Snel","year":"2000","unstructured":"Snel B, Lehmann G, Bork P, Huynen MA (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28(18):3442\u20133444","journal-title":"Nucleic Acids Res"},{"key":"4639_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/nar\/gkw937","volume":"45:D","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45:D:362\u2013368","journal-title":"Nucleic Acids Res"},{"key":"4639_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10:717\u2013728","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4639_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2184.2009.00640.x","volume":"42","author":"D Giuffrida","year":"2009","unstructured":"Giuffrida D, Rogers IM, Nagy A, Calogero AE, Brown TJ, Casper RF (2009) Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif 42(6):788\u2013798. \n                    https:\/\/doi.org\/10.1111\/j.1365-2184.2009.00640.x\n                    \n                   PMID: 19732065","journal-title":"Cell Prolif"},{"issue":"1","key":"4639_CR42","doi-asserted-by":"publisher","first-page":"e0169899","DOI":"10.1371\/journal.pone.0169899","volume":"9","author":"S Zhou","year":"2017","unstructured":"Zhou S, Abdouh M, Arena V, Arena M, Arena GO (2017) Reprogramming malignant cancer cells by human embryonic stem cell. PLoS ONE 9(1):e0169899. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0169899","journal-title":"PLoS ONE"},{"key":"4639_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499\u2013507","journal-title":"Nat Genet"},{"key":"4639_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/onc.2013.547","volume":"34","author":"H Hayashi","year":"2013","unstructured":"Hayashi H, Arao T, Togashi Y, Kato H, Fujita Y, De Velasco MA, Kimura H, Matsumoto K, Tanaka K, Okamoto I, Ito A, Yamada Y, Nakagawa K, Nichio K (2013) The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer. Oncogene 34:199\u2013208","journal-title":"Oncogene"},{"issue":"3","key":"4639_CR45","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/nar\/gkv024","volume":"43","author":"Y-A Tang","year":"2015","unstructured":"Tang Y-A, Chen C-H, Sun SH, Cheng C-P, Tseng VS, Hsu H-S, Su W-C, Lai W-W, Wang Y-C (2015) Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer. Nucleic Acids Res 43(3):1593\u20131608. \n                    https:\/\/doi.org\/10.1093\/nar\/gkv024","journal-title":"Nucleic Acids Res"},{"key":"4639_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2016.03.064","volume":"473","author":"I Kobayashi","year":"2016","unstructured":"Kobayashi I, Takahashi F, Nurwidya F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K (2016) Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells. Biochem Biophys Res Commun 473:125\u2013132","journal-title":"Biochem Biophys Res Commun"},{"key":"4639_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.bbagrm.2016.03.013","volume":"1859","author":"D Onichtchouk","year":"2016","unstructured":"Onichtchouk D (2016) Evolution and functions of Oct4 homologs in non-mammalian vertebrates. Biochim Biophys Acta 1859:770\u2013779. \n                    https:\/\/doi.org\/10.1016\/j.bbagrm.2016.03.013","journal-title":"Biochim Biophys Acta"},{"key":"4639_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.stem.2007.09.003","volume":"1","author":"S Liedtke","year":"2007","unstructured":"Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Ko\u00a8gler G (2007) Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1:364\u2013366. \n                    https:\/\/doi.org\/10.1016\/j.stem.2007.09.003","journal-title":"Cell Stem Cell"},{"issue":"7","key":"4639_CR49","doi-asserted-by":"publisher","first-page":"e104296","DOI":"10.1371\/journal.pone.0104296","volume":"9","author":"M Jez","year":"2014","unstructured":"Jez M, Ambady S, Kashpur O, Grella A, Malcuit C, Vilner L, Rozman P, Dominko T (2014) Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells. PLoS ONE 9(7):e104296. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0089546","journal-title":"PLoS ONE"},{"key":"4639_CR50","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1038\/ncomms8631","volume":"6","author":"M Scarola","year":"2015","unstructured":"Scarola M, Comisso E, Pascolo R, Chiaradia R, Marion RM, Schneider C, Blasco MA, Schoeftner S, Benetti R (2015) Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nat Commun 6:7631. \n                    https:\/\/doi.org\/10.1038\/ncomms8631","journal-title":"Nat Commun"},{"key":"4639_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.leukres.2016.01.008","volume":"42","author":"M Carrett-Dias","year":"2016","unstructured":"Carrett-Dias M, Almeida LK, Pereira JL, Almeida DV, Filgueira DMVB, Marins LF, Votto APdeS, Trindade GS (2016) Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells. Leuk Res 42:13\u201320. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2016.01.2018","journal-title":"Leuk Res"},{"issue":"16","key":"4639_CR52","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-13-3553","volume":"74","author":"XK Wang","year":"2014","unstructured":"Wang XK, He JH, Xu JH, Ye S, Wang F, Zhang H, Huang ZC, To KK, Fu LW (2014) Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells. Cancer Res 74(16):4431\u20134445. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3553","journal-title":"Cancer Res"},{"key":"4639_CR53","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhang H, Peng C, Li S (2009) Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41:783\u2013792","journal-title":"Nat Genet"},{"key":"4639_CR54","first-page":"5130","volume":"58","author":"DW Loe","year":"1998","unstructured":"Loe DW, Deeley RG, Cole SP (1998) Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 58:5130\u20135136","journal-title":"Cancer Res"},{"issue":"3","key":"4639_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0195-5616(03)00004-4","volume":"33","author":"PJ Bergman","year":"2003","unstructured":"Bergman PJ (2003) Mechanisms of anticancer drug resistance. Vet Clin Small Anim 33(3):651\u2013667","journal-title":"Vet Clin Small Anim"},{"key":"4639_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-60761-416-6_14","volume":"596","author":"CH Lee","year":"2010","unstructured":"Lee CH (2010) Reversing agents for ATP-binding cassette drug transporters. Methods Mol Bio 596:325\u2013340. \n                    https:\/\/doi.org\/10.1007\/978-1-60761-416-6_14","journal-title":"Methods Mol Bio"},{"key":"4639_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2017.03.008","volume":"396","author":"Y Li","year":"2017","unstructured":"Li Y, Atkinson K, Zhang T (2017) Combination of chemotherapy and cancer stem cell targeting agents: Preclinical and clinical studies. Cancer Lett 396:103\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2017.03.008","journal-title":"Cancer Lett"},{"key":"4639_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","volume":"26","author":"JI Fletcher","year":"2016","unstructured":"Fletcher JI, Williams RT, Henderson MJ, Norris MD, Haber M (2016) ABC transporters as mediators of drug resistance and contributors tocancer cell biology. Drug Resist Upat 26:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.drup.2016.03.001","journal-title":"Drug Resist Upat"},{"key":"4639_CR59","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/sj.bjc.6604010","volume":"97","author":"DJA Groot De","year":"2007","unstructured":"De Groot DJA, Van der Deen M, Le TKP, Regeling A, De Jong S, De Vries EGE (2007) Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1. Br J Cancer 97:1077\u20131083","journal-title":"Br J Cancer"},{"key":"4639_CR60","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/0006-291X(84)90878-7","volume":"119","author":"FA Nicholls","year":"1984","unstructured":"Nicholls FA, Ahokas JT (1984) Inhibition of purified glutathione Stransferases by indomethacin. Biochem Biophys Res Commun 119:1034\u20131038","journal-title":"Biochem Biophys Res Commun"},{"key":"4639_CR61","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cca.2009.12.026","volume":"411","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H (2010) Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta 411:459\u2013466","journal-title":"Clin Chim Acta"},{"issue":"6","key":"4639_CR62","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.3390\/molecules18066584","volume":"18","author":"Y-C Guo","year":"2013","unstructured":"Guo Y-C, Chang C-M, Hsu W-L, Chiu S-J, Tsai Y-T, Chou Y-H, Hou M-F, Wang J-Y, Lee M-H, Tsai K-L, Chang W-C (2013) Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization. Molecules 18(6):6584\u20136596. \n                    https:\/\/doi.org\/10.3390\/molecules18066584","journal-title":"Molecules"},{"issue":"8","key":"4639_CR63","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.leukres.2014.06.001","volume":"38","author":"MAM Moreira","year":"2014","unstructured":"Moreira MAM, Bagni C, de Pinho MB, Mac-Cormick TM, dos Santos Mota M, Pinto-Silva FE, Daflon-Yunes N, Rumjanek VM (2014) Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line. Leuk Res 38(8):983\u2013987. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2014.06.001","journal-title":"Leuk Res"},{"key":"4639_CR64","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1242\/dev.024398","volume":"136","author":"I Chambers","year":"2009","unstructured":"Chambers I, Tomlinson SR (2009) The transcriptional foundation of pluripotency. Development 136:2311\u20132322","journal-title":"Development"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-04639-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:09:05Z","timestamp":1580843345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-04639-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4639"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-04639-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}